The Yamamoto team demonstrated in vitro that tumor-specific autophagy inhibition using CQ drives increased MHC antigen presentation in a pancreatic ductal adenocarcinoma (PDAC) model, enhancing CD8+ T cell proliferation, activation, and tumor cell killing [34]. Here, CD8A is linked to neoplasm.